» Articles » PMID: 8443302

Meningococcal Disease in The Netherlands, 1958-1990: a Steady Increase in the Incidence Since 1982 Partially Caused by New Serotypes and Subtypes of Neisseria Meningitidis

Overview
Journal Clin Infect Dis
Date 1993 Feb 1
PMID 8443302
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

In order to explain a threefold increase in the incidence of meningococcal disease in the Netherlands during the 1980s, we serotyped and subtyped Neisseria meningitidis isolates recovered between 1958 and 1990 from > 3,000 patients with systemic disease. No single strain could be held responsible for the increase. Apart from the newly introduced strain B:4:P1.4, which became the most prevalent phenotype in 1990 (21% of all isolates), the majority of the cases in 1990 were caused by many different strains that were already present in the Netherlands before 1980. For the period 1980-1990, a shift in the age distribution of patients with meningococcal disease from younger to older age categories was found, particularly with regard to cases due to meningococci of serogroup B; this shift is explained by the changing distribution of serotypes and subtypes within serogroup B. A polyvalent group B, class 1 outer-membrane-protein vaccine of a stable composition could theoretically have prevented approximately 80% of all group B meningococcal infections in the Netherlands during the past 30 years.

Citing Articles

The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: potential implications of emergence of new strains.

Gilca R, Deceuninck G, Lefebvre B, Tsang R, Amini R, Gilca V PLoS One. 2012; 7(11):e50659.

PMID: 23209803 PMC: 3510192. DOI: 10.1371/journal.pone.0050659.


Clonal analysis of Neisseria meningitidis serogroup B strains in South Africa, 2002 to 2006: emergence of new clone ST-4240/6688.

Moodley C, du Plessis M, Ndlangisa K, de Gouveia L, Klugman K, von Gottberg A J Clin Microbiol. 2012; 50(11):3678-86.

PMID: 22972827 PMC: 3486271. DOI: 10.1128/JCM.01079-12.


The elusive meningococcal meningitis serogroup: a systematic review of serogroup B epidemiology.

Racloz V, Luiz S BMC Infect Dis. 2010; 10:175.

PMID: 20565757 PMC: 2894839. DOI: 10.1186/1471-2334-10-175.


Vaccine preventability of meningococcal clone, Greater Aachen Region, Germany.

Elias J, Schouls L, van de Pol I, Keijzers W, Martin D, Glennie A Emerg Infect Dis. 2010; 16(3):465-72.

PMID: 20202422 PMC: 3322024. DOI: 10.3201/eid1603.091102.


Characterization of serogroup A Neisseria meningitidis from invasive meningococcal disease cases in Canada between 1979 and 2006: Epidemiological links to returning travellers.

Sloan A, Henderson A, Tsang R Can J Infect Dis Med Microbiol. 2009; 19(3):227-32.

PMID: 19412379 PMC: 2605869. DOI: 10.1155/2008/523021.